Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection

Nigel Bourne, L. R. Stanberry, E. R. Kern, G. Holan, B. Matthews, D. I. Bernstein

Research output: Contribution to journalArticle

157 Citations (Scopus)

Abstract

Dendrimers are large highly branched macromolecules synthesized from a polyfunctional core. They have shown a variety of biological properties, including, in some instances, antiviral activity. In this study, five dendrimers were evaluated for in vitro activity against herpes simplex virus (HSV) types 1 and 2 by cytopathic effect (CPE) inhibition and plaque reduction (PR) assay in human foreskin fibroblast cells. All of the compounds were active against both virus types in the CPE inhibition assay, in which drug was added to the cells prior to the addition of virus. Antiviral activity was reduced or lost in the PR assays, in which the cells were incubated with the virus before the drug was added. The prophylactic efficacy suggested that the dendrimers might have potential as topical microbicides, products intended to be applied to the vaginal or rectal mucosa to protect against sexually transmitted infections. Three dendrimers were evaluated for this application against genital HSV infection in mice. Two of the compounds, BRI-2999 and BRI-6741, significantly reduced infection rates when 15 μl of a 100-mg/ml solution was administered immediately prior to intravaginal challenge, and the most effective compound, BRI-2999, provided significant protection even when applied 30 min before challenge. This is the first report of microbicidal activity by dendrimers in vivo.

Original languageEnglish (US)
Pages (from-to)2471-2474
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume44
Issue number9
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Dendrimers
Local Anti-Infective Agents
Virus Diseases
Simplexvirus
Viruses
Antiviral Agents
Foreskin
Herpes Genitalis
Human Herpesvirus 2
Human Herpesvirus 1
Sexually Transmitted Diseases
Pharmaceutical Preparations
Mucous Membrane
Fibroblasts
Infection

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection. / Bourne, Nigel; Stanberry, L. R.; Kern, E. R.; Holan, G.; Matthews, B.; Bernstein, D. I.

In: Antimicrobial Agents and Chemotherapy, Vol. 44, No. 9, 2000, p. 2471-2474.

Research output: Contribution to journalArticle

Bourne, Nigel ; Stanberry, L. R. ; Kern, E. R. ; Holan, G. ; Matthews, B. ; Bernstein, D. I. / Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection. In: Antimicrobial Agents and Chemotherapy. 2000 ; Vol. 44, No. 9. pp. 2471-2474.
@article{215bc08d8b1d441ba0c06abc6fefcfd0,
title = "Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection",
abstract = "Dendrimers are large highly branched macromolecules synthesized from a polyfunctional core. They have shown a variety of biological properties, including, in some instances, antiviral activity. In this study, five dendrimers were evaluated for in vitro activity against herpes simplex virus (HSV) types 1 and 2 by cytopathic effect (CPE) inhibition and plaque reduction (PR) assay in human foreskin fibroblast cells. All of the compounds were active against both virus types in the CPE inhibition assay, in which drug was added to the cells prior to the addition of virus. Antiviral activity was reduced or lost in the PR assays, in which the cells were incubated with the virus before the drug was added. The prophylactic efficacy suggested that the dendrimers might have potential as topical microbicides, products intended to be applied to the vaginal or rectal mucosa to protect against sexually transmitted infections. Three dendrimers were evaluated for this application against genital HSV infection in mice. Two of the compounds, BRI-2999 and BRI-6741, significantly reduced infection rates when 15 μl of a 100-mg/ml solution was administered immediately prior to intravaginal challenge, and the most effective compound, BRI-2999, provided significant protection even when applied 30 min before challenge. This is the first report of microbicidal activity by dendrimers in vivo.",
author = "Nigel Bourne and Stanberry, {L. R.} and Kern, {E. R.} and G. Holan and B. Matthews and Bernstein, {D. I.}",
year = "2000",
doi = "10.1128/AAC.44.9.2471-2474.2000",
language = "English (US)",
volume = "44",
pages = "2471--2474",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "9",

}

TY - JOUR

T1 - Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection

AU - Bourne, Nigel

AU - Stanberry, L. R.

AU - Kern, E. R.

AU - Holan, G.

AU - Matthews, B.

AU - Bernstein, D. I.

PY - 2000

Y1 - 2000

N2 - Dendrimers are large highly branched macromolecules synthesized from a polyfunctional core. They have shown a variety of biological properties, including, in some instances, antiviral activity. In this study, five dendrimers were evaluated for in vitro activity against herpes simplex virus (HSV) types 1 and 2 by cytopathic effect (CPE) inhibition and plaque reduction (PR) assay in human foreskin fibroblast cells. All of the compounds were active against both virus types in the CPE inhibition assay, in which drug was added to the cells prior to the addition of virus. Antiviral activity was reduced or lost in the PR assays, in which the cells were incubated with the virus before the drug was added. The prophylactic efficacy suggested that the dendrimers might have potential as topical microbicides, products intended to be applied to the vaginal or rectal mucosa to protect against sexually transmitted infections. Three dendrimers were evaluated for this application against genital HSV infection in mice. Two of the compounds, BRI-2999 and BRI-6741, significantly reduced infection rates when 15 μl of a 100-mg/ml solution was administered immediately prior to intravaginal challenge, and the most effective compound, BRI-2999, provided significant protection even when applied 30 min before challenge. This is the first report of microbicidal activity by dendrimers in vivo.

AB - Dendrimers are large highly branched macromolecules synthesized from a polyfunctional core. They have shown a variety of biological properties, including, in some instances, antiviral activity. In this study, five dendrimers were evaluated for in vitro activity against herpes simplex virus (HSV) types 1 and 2 by cytopathic effect (CPE) inhibition and plaque reduction (PR) assay in human foreskin fibroblast cells. All of the compounds were active against both virus types in the CPE inhibition assay, in which drug was added to the cells prior to the addition of virus. Antiviral activity was reduced or lost in the PR assays, in which the cells were incubated with the virus before the drug was added. The prophylactic efficacy suggested that the dendrimers might have potential as topical microbicides, products intended to be applied to the vaginal or rectal mucosa to protect against sexually transmitted infections. Three dendrimers were evaluated for this application against genital HSV infection in mice. Two of the compounds, BRI-2999 and BRI-6741, significantly reduced infection rates when 15 μl of a 100-mg/ml solution was administered immediately prior to intravaginal challenge, and the most effective compound, BRI-2999, provided significant protection even when applied 30 min before challenge. This is the first report of microbicidal activity by dendrimers in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0033836059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033836059&partnerID=8YFLogxK

U2 - 10.1128/AAC.44.9.2471-2474.2000

DO - 10.1128/AAC.44.9.2471-2474.2000

M3 - Article

C2 - 10952597

AN - SCOPUS:0033836059

VL - 44

SP - 2471

EP - 2474

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 9

ER -